Related Experiment Videos
Re-evaluating natural resistance to herpes simplex virus type 1
William P Halford1, John W Balliet, Bryan M Gebhardt
1Department of Microbiology and Immunology, Tulane University Medical School, New Orleans, LA, USA. halford@montana.edu
Journal of Virology
|August 28, 2004
Summary
Mice show similar susceptibility to herpes simplex virus type 1 (HSV-1) replication and latency, despite differences in disease severity. This challenges the idea that natural resistance explains human herpes simplex virus (HSV) recurrence.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Innate resistance to herpes simplex virus type 1 (HSV-1) varies among individuals.
- Previous studies showed C57BL/6 mice are resistant to HSV-1 encephalitis, unlike BALB/c mice.
- The impact of this resistance on other stages of HSV-1 infection remained unclear.
Purpose of the Study:
- To investigate differences in HSV-1 pathogenesis, replication, spread, and latent infection establishment between resistant (C57BL/6) and susceptible (BALB/c) mouse strains.
- To clarify the mechanisms underlying differential susceptibility to HSV-1 infection.
Main Methods:
- Comparative analysis of HSV-1 infection dynamics in C57BL/6 and BALB/c mice.
- Assessment of viral entry, replication, spread, and establishment of latency.
- Evaluation of pathogenesis and mortality rates.
Main Results:
- C57BL/6 mice exhibit greater resistance to HSV-1 pathogenesis and mortality compared to BALB/c mice.
- HSV-1 enters, replicates, spreads, and establishes latent infections with nearly identical efficiency in both mouse strains.
- Despite differing disease outcomes, the fundamental infection process is conserved across strains.
Conclusions:
- Differences in natural resistance do not significantly impact HSV-1 replication, spread, or latency establishment.
- The observed resistance in C57BL/6 mice primarily affects pathogenesis, not the virus's ability to infect and persist.
- These findings question the relevance of natural resistance in explaining human herpes simplex virus (HSV) recurrence versus asymptomatic carriage.